aTyr Pharma Financials - Benzinga

aTyr Pharma Inc

ATYRNASDAQ

Trade with Public

Trade with Public

$0.5590

0.0061.08%

At close: Aug 14, 5:00 PM EST

$0.5291

-0.0299-5.35%

After Hours: Aug 14, 5:19 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

aTyr Pharma Financials

aTyr Pharma (ATYR) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
aTyr Pharma Q2 EPS $(0.11) Beats $(0.12) Estimate

aTyr Pharma (NASDAQ:ATYR) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 8.33 percent. This is a 50 percent increase over losses of $(0.22) per share from the same

Benzinga Newsdesk

PRO
aTyr Pharma Q1 EPS $(0.11) Beats $(0.14) Estimate

aTyr Pharma (NASDAQ:ATYR) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 35.29 percent increase over losses of $(0.17) per share from the

Benzinga Newsdesk

PRO
aTyr Pharma Q4 EPS $(0.14) Beats $(0.16) Estimate

aTyr Pharma (NASDAQ:ATYR) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.16) by 13.04 percent. This is a 22.22 percent increase over losses of $(0.18) per share from the

Benzinga Newsdesk

PRO
aTyr Pharma Q3 EPS $(0.26) Misses $(0.18) Estimate

Benzinga Newsdesk

Crude Oil Rises 1%; Manufacturing Activity in New York Falls In September

Avi Kapoor

Nasdaq Gains Over 100 Points; Tesla Shares Spike Higher

Avi Kapoor